| __timestamp | BioCryst Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 5280000 |
| Thursday, January 1, 2015 | 72758000 | 7148000 |
| Friday, January 1, 2016 | 61008000 | 19594000 |
| Sunday, January 1, 2017 | 66962000 | 22894000 |
| Monday, January 1, 2018 | 84888000 | 50337000 |
| Tuesday, January 1, 2019 | 107068000 | 109450000 |
| Wednesday, January 1, 2020 | 122964000 | 90450000 |
| Friday, January 1, 2021 | 208808000 | 104128000 |
| Saturday, January 1, 2022 | 253297000 | 108630000 |
| Sunday, January 1, 2023 | 216566000 | 134951000 |
In pursuit of knowledge
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, BioCryst Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical science.
BioCryst has consistently increased its R&D spending, peaking in 2022 with a 390% rise from 2014. This surge underscores their strategic focus on developing groundbreaking treatments.
Rhythm Pharmaceuticals, while starting with modest R&D expenses in 2014, has shown a remarkable growth trajectory, with a 2,455% increase by 2023. This highlights their aggressive pursuit of innovative solutions in the pharmaceutical sector.
Both companies exemplify the dynamic nature of the biopharmaceutical industry, where substantial R&D investments are pivotal for future breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: argenx SE vs BioCryst Pharmaceuticals, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs BioCryst Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds
R&D Spending Showdown: Perrigo Company plc vs BioCryst Pharmaceuticals, Inc.
Comparing Innovation Spending: Agios Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioCryst Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.